A detailed history of Zions Bancorporation, N.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 31 shares of REGN stock, worth $21,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 37 16.22%
Holding current value
$21,757
Previous $38,000 15.79%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$1024.09 - $1201.76 $6,144 - $7,210
-6 Reduced 16.22%
31 $32,000
Q2 2024

Aug 08, 2024

SELL
$883.2 - $1071.19 $6,182 - $7,498
-7 Reduced 15.91%
37 $38,000
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $5,416 - $5,960
-6 Reduced 12.0%
44 $42,000
Q4 2023

Feb 12, 2024

SELL
$775.18 - $881.7 $1,550 - $1,763
-2 Reduced 3.85%
50 $43,000
Q1 2023

May 10, 2023

SELL
$680.49 - $826.97 $2,721 - $3,307
-4 Reduced 7.14%
52 $42,000
Q4 2022

Feb 10, 2023

BUY
$705.89 - $766.39 $2,823 - $3,065
4 Added 7.69%
56 $40,000
Q3 2022

Nov 08, 2022

BUY
$573.97 - $724.32 $3,443 - $4,345
6 Added 13.04%
52 $36,000
Q2 2022

Aug 05, 2022

SELL
$548.35 - $738.84 $11,515 - $15,515
-21 Reduced 31.34%
46 $27,000
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $7,141 - $8,381
12 Added 21.82%
67 $47,000
Q4 2021

Feb 11, 2022

BUY
$543.48 - $670.97 $7,065 - $8,722
13 Added 30.95%
55 $35,000
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $1,148 - $1,361
2 Added 5.0%
42 $25,000
Q2 2021

Aug 11, 2021

SELL
$472.8 - $558.54 $7,092 - $8,378
-15 Reduced 27.27%
40 $22,000
Q1 2021

May 13, 2021

BUY
$446.73 - $548.2 $9,828 - $12,060
22 Added 66.67%
55 $26,000
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $1,434 - $1,823
3 Added 10.0%
33 $16,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $1,634 - $1,974
3 Added 11.11%
30 $17,000
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $8,879 - $11,590
18 Added 200.0%
27 $17,000
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $1,344 - $1,977
-4 Reduced 30.77%
9 $4,000
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $8,772 - $12,048
-32 Reduced 71.11%
13 $5,000
Q3 2019

Nov 13, 2019

BUY
$273.46 - $318.39 $4,101 - $4,775
15 Added 50.0%
45 $12,000
Q2 2019

Jul 09, 2019

SELL
$299.6 - $414.82 $3,295 - $4,563
-11 Reduced 26.83%
30 $9,000
Q1 2019

May 10, 2019

SELL
$372.08 - $439.57 $122,042 - $144,178
-328 Reduced 88.89%
41 $17,000
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $123,917 - $148,721
369 New
369 $138,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.